Merck
CN
  • Cerebrotendinous xanthomatosis: a rare cause of spinocerebellar syndrome.

Cerebrotendinous xanthomatosis: a rare cause of spinocerebellar syndrome.

Neurologia i neurochirurgia polska (2012-01-04)
Monika Ostrowska, Krzysztof Banaszkiewicz, Anna Kiławiec, Teresa Róg, Dieter Lütjohann, Andrzej Szczudlik
摘要

A 34-year-old patient demonstrating pyramidal and cerebellar signs, accompanied by epilepsy, peripheral neuropathy, mental retardation and bilateral cataract was diagnosed with cerebrotendinous xanthomatosis based on the clinical picture, magnetic resonance imaging of the brain and serum sterol analysis. Tendon xanthomas were not observed in this case. After establishing the diagnosis, treatment with chenodeoxycholic acid and statin was introduced. During the next two years of the follow-up, serum cholestanol and 7α-hydroxycholesterol levels decreased in response to the therapy, but this was not reflected in the patient's neurological condition, which was slowly progressing. Treatment effectiveness in cerebrotendinous xanthomatosis is variable, notably better in patients who had started therapy before the injury to the nervous system took place. The present case report points to cerebrotendinous xanthomatosis as a rare cause of spinocerebellar syndrome, which might be treatable if diagnosed in early life.

材料
货号
品牌
产品描述

Sigma-Aldrich
αβ二氢胆固醇, ≥95%
Sigma-Aldrich
5β-胆甾烷-3α-醇, ≥95%
Sigma-Aldrich
5-胆甾烯-3β-醇-7-酮, ≥90%
Sigma-Aldrich
粪甾烷-3-醇, ≥98%
Supelco
胆甾烷醇, certified reference material, 10 mg/mL in chloroform